αAlphaSMO
IBRX

IBRX 13F Institutional Holders

Immunitybio INC

+$1.2B

Net Activity

Institutions Holding

392

Popularity Rank

#1483

Avg Weight

0.06%

Total Value

$1.6B

Ownership Trend

392 institutions currently hold IBRX, with 288 net buyers and 87 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

87

Net Buying Institutions

288

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$202.1M
SS
State Street CORP
$135.8M
VP
Vanguard Portfolio Management LLC
$125.2M
VC
Vanguard Capital Management LLC
$116.0M
DE
D. E. Shaw & Co., Inc.
$96.4M

Top 5 by Conviction

GP
Great Point Partners LLC
5.29%
KA
Kercheville Advisors, LLC
1.58%
AH
Allen Holding INC /ny
0.52%
AA
Affinity Asset Advisors, LLC
0.50%
SS
Sheets Smith Wealth Management
0.48%
View all 392 holding institutions

Quarterly Activity

Recent Activity

+$1.1B

Total Buy Value

$117.9M

Total Sell Value

New buy142
Trim56
Add146
Sold out31

288

Net Buyers

87

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

5

Filings (90d)

$6.39M

Total Est. Value

655K shares

Planned Shares

Last Filed 2026-07-02
FilerFiling DateEst. Value
CHERYL L COHEN2026-07-02$1.21M
CHRISTOBEL SELECKY2026-07-01$1.40M
Selecky Christobel2026-06-30$9K
Selecky Christobel2026-06-29$834K
Simon Barry J.2026-06-04$2.95M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding IMMUNITYBIO INC (IBRX)?
Major stakeholders currently include BlackRock, Inc. ($202.1M), State Street CORP ($135.8M), Vanguard Portfolio Management LLC ($125.2M). Based on the latest 13F filings, there are a total of 392 tracked investment funds and institutions maintaining positions in IBRX.
What is the overall institutional sentiment toward IBRX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.2B, driven by 288 managers accumulating shares while 87 reduced their exposure.
Which institutions have been selling or reducing their IBRX positions?
In the latest period, 56 funds trimmed their holdings, and 31 managers completely exited their positions. The aggregate reported sell value was $117.9M.
Are there any notable investors adding IBRX to their portfolios?
Yes, buying activity remains notable. 142 institutions opened new positions in {ticker}, and 146 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.1B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

358 institutions currently hold both IBRX and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

355 institutions currently hold both IBRX and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

353 institutions currently hold both IBRX and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail